Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01882036 · ClinicalTrials.gov registry record · NA

Bariatric Surgery And Adipose Inflammation Dysfunction and Type 2 Diabetes Mellitus

A NA study, sponsored by University of Minnesota.

Completed
Registry status
NA
Development phase
57
Enrollment target

NCT01882036: Completed NA study, sponsored by University of Minnesota.

NCT01882036 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 57 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01882036, a NA study, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
NA
Development phase
57 participants
Enrollment target

Study Summary

The focus of this proposal is to define the mechanism by which bariatric surgery acutely improves insulin sensitivity. Our central hypothesis is that drastically reduced caloric intake early after Bariatric surgery improves the pro-inflammatory profile of macrophages, which in turn improves insulin sensitivity and glucose homeostasis.

Interventions

  • OTHER Hypocaloric diet
  • PROCEDURE Gastric Bypass w/ matched hypocaloric diet

Trial Details

FieldValue
Enrollment Target 57 participants
Start Date 2011-11
Est. Completion 2018-07-10
Phase NA
University of Minnesota

966 total trials

What the finished NCT01882036 record still lists

NCT01882036 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 57 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 2 interventions - of which Hypocaloric diet is the first listed.

NCT01882036 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01882036 about?

NCT01882036 is a clinical study titled "Bariatric Surgery And Adipose Inflammation Dysfunction and Type 2 Diabetes Mellitus". The focus of this proposal is to define the mechanism by which bariatric surgery acutely improves insulin sensitivity. Our central hypothesis is that drastically reduced caloric intake early after Bariatric surgery improves the pro-inflammatory profile of macrophages, which in turn improves insulin ...

What is the current status of trial NCT01882036?

This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2011-11. Estimated completion is 2018-07-10.

What interventions are being tested in trial NCT01882036?

The interventions under investigation include: Hypocaloric diet (OTHER), Gastric Bypass w/ matched hypocaloric diet (PROCEDURE).

Who is sponsoring clinical trial NCT01882036?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01882036's enrollment target sits among peer trials

57 1261st of 2000 higher than 739 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03521830 · 57 participants · Phase 2

    Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma

  • NCT03587701 · 57 participants · Phase 2

    Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease

  • NCT04104126 · 57 participants · NA

    Blood Flow Restriction Therapy in Achilles Injury

  • NCT04703842 · 57 participants · Phase 1

    Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01882036, the US trial registry maintained by the National Library of Medicine. NCT01882036 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.